Stock·NYSE·Basic Materials
Freeport-McMoRan Inc. (FCX)
- Market cap
- $94.71B
- P/E
- 32.49
- Dividend yield
- 0.91%
- Street target
- $82.00median of 23 analysts
- 52-week range
- $38.54 $80.24
FCX stock forecast today
Where FCX stands today, and what CleaRank Financial AI makes of it.
FCX at a glance
Freeport-McMoRan Inc. (FCX): Hold, 51/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 200-day but below its 50-day moving average ($65.13 and $71.81).
- Earnings FCX beat estimates in 7 of its last 7 quarters, yet fell the next day after 5 of those beats.
- Insiders Insiders sold $46.4M and made no open-market purchases over the last 18 months.
- Valuation P/E of 32.5 against 30.2 for the Basic Materials sector: broadly in line with peers (+8%).
Figures as of October 27, 2026.
CleaRank Financial AI
FCX is rated Hold by CleaRank, with a model score of 51/100.
Analysts lift that score the most: 18 of 23 rate the stock a buy, and the median target sits 24.3% above the price. Momentum pulls the score down the most, as the 14-day RSI of 37.2 is in the bearish zone and the MACD line is negative. Rather than a clear direction, the trend is mixed, with Freeport-McMoRan Inc. (FCX) trading 8.16% below its 50-day average of $71.81 yet 1.26% above its 200-day average of $65.13. The price has climbed 60.46% over the past year.
Only on CleaRank
Figures we compute ourselves from FCX's own price, earnings and insider-filing history. Tap one to see it in context.
FCX stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
3/4Price above its 50-day average ›
The price of $65.95 is 8.2% below the 50-day simple moving average of $71.81.Price above its 200-day average ›
The price is 1.3% above the 200-day simple moving average of $65.13.50-day average above the 200-day ›
The 50-day average ($71.81) is 10.3% above the 200-day average ($65.13), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 66% of its 52-week range, between $38.54 and $80.24.
FCX share price
Pick a period: each tab shows how far FCX has moved over it, to the last close.
Today's trading
Where FCX sits inside today's range and its 52-week range.
FCX fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 32.49 is 7.6% above the Basic Materials median of 30.2.P/S below the sector median ›
The price-to-sales ratio of 3.66 is 12.8% below the sector median of 4.2.Profitable over the last 12 months ›
Net income over the last 12 months was $4.6B on revenue of $25.9B, a net margin of 17.7%.Beat estimates in most recent reports ›
FCX beat the EPS estimate in 7 of its last 7 reports.Pays a dividend ›
The trailing dividend yield is 0.91%, or $0.6 a share a year.
Key statistics
The headline figures for FCX.
As of October 27, 2026, FCX trades at $65.95, with a market value of $94.71B, a P/E ratio of 32.49 and a dividend yield of 0.91%.
What the numbers say
CleaRank Financial AI's reading of FCX's valuation, growth and risks.
Freeport-McMoRan Inc. (FCX) looks broadly in line with its peers on earnings. Its P/E of 32.49 is 7.6% above the 30.2 sector median for Basic Materials, a gap that the P/E verdict of broadly in line with peers puts in context. On sales, the P/S of 3.66 sits 12.9% below the sector median of 4.2. The company is valued at $94.7B, and its trailing earnings come to $2.03 per share.
FCX's revenue shrank 7.30% year on year in the latest quarter, which leaves it 26.3 percentage points behind the Basic Materials sector median of 19.0%. Even so, the company converts sales into earnings well, with a net margin of 17.7% and an operating margin of 33.40%. Its return on equity of 14.76% sits below the sector median of 17.9%. Debt-to-equity is 0.32, and the trailing dividend yield is 0.91%, or $0.60 per share each year.
FCX reported $0.74 per share in its most recent quarter, reported on July 23, 2026, compared with an estimate of $0.62. That was a beat of 19.35% over the estimate. The share price nonetheless slipped 1.42% in the first session after the report.
FCX has beaten the EPS estimate in all 7 of its recent reports, though the stock still fell in the first session after 5 of those 7 beats. Analysts' average EPS estimate for this fiscal year is $3.20, which would be growth of 80.8%, and $4.36 for next year (growth of 36.1%).
The 30-day standard deviation of FCX's daily returns is 2.03%; measured against the S&P 500, its beta is 1.39. The price is 17.81% below its 52-week high of $80.24. Over the last 18 months, insider sales totalled $46.4M with no open-market purchases; planned sales and tax sales on vesting shares make selling a weaker signal than buying.
FCX against the Basic Materials sector
How FCX compares with the median Basic Materials stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (8% difference), suggesting fair market pricing relative to industry standards.
Return vs XLB: Since May 15, 2025, FCX has gained 71.4% against a gain of 20.2% for XLB.
Performance against XLB
FCX and the Basic Materials sector fund over the same days.
Revenue and earnings
How much FCX sells, and how much of it becomes profit.
Revenue growth: Revenue grew 1.8% in FY2025 to $25.9B, from $25.5B a year earlier.
Profit margin: The net margin was 16.0% in FY2025, down from 17.3% the year before.
Profitable: FCX earned $4.2B in FY2025.
Earnings reality check
Did FCX beat what analysts expected, and how did the stock react?
Earnings record: FCX beat the analyst estimate in 7 of the last 7 quarters.
Market reaction: The stock fell in the first session after 5 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 23, 2026after close | $0.62 | $0.74 | +19.35% | -1.42% | -0.09% |
| Apr 23, 2026after close | $0.47 | $0.57 | +21.28% | -0.70% | -6.02% |
| Jan 22, 2026after close | $0.32 | $0.47 | +46.88% | +2.65% | +10.67% |
| Oct 23, 2025after close | $0.41 | $0.50 | +21.95% | +0.34% | +1.21% |
| Jul 23, 2025after close | $0.44 | $0.54 | +22.73% | -0.58% | -12.71% |
| Apr 24, 2025after close | $0.23 | $0.24 | +4.35% | -0.74% | -3.24% |
| Jan 23, 2025after close | $0.22 | $0.31 | +40.91% | -1.79% | -4.83% |
As of October 27, 2026, FCX has beaten the analyst EPS estimate in 7 of its last 7 reported quarters and fell in the first trading session after 5 of those beats; its latest report, on July 23, 2026, came in 19.35% above the estimate and the stock moved -1.42% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
FCX AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 37.2, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 37.2 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of FCX
The score, the reasoning behind it, and what could move the price next.
Freeport-McMoRan Inc. (FCX) is caught between its two moving averages. At $65.95, the stock trades 1.26% above its 200-day average of $65.13, yet it sits 8.16% below the 50-day average of $71.81. That 50-day average is 10.26% above the 200-day one, and the gap would likely shrink if the price keeps trading under the shorter average. Within its 52-week range, running from $38.54 to $80.24, the price stands at 66%.
A recent pullback sits inside a stronger longer record: the price fell 8.80% over the past month, rose 6.99% over the past three months and rose 60.46% over the past year. On momentum, the 14-day RSI reads 37.2, in the bearish zone, above the oversold line, with the MACD line negative.
Rating reaffirmed ›
Barclays kept its Overweight rating on October 19, 2026.
Source: Analyst action, Barclays, October 19, 2026
Earnings beat, but the stock fell ›
The July 23, 2026 report beat the EPS estimate by 19.35%, and the share price fell 1.42% in the first session after it.
Source: Earnings report, July 23, 2026
- Keep an eye on the two closest levels: the 20-day EMA at $69.02, which sits above the price, and the 200-day SMA at $65.13, which sits below it.
- With the MACD line negative, the 14-day RSI at 37.2 sits in the bearish zone. Readings above 70 or below 30 signal stretched momentum.
- FCX's share price fell 1.42% in the first session after its July 23, 2026 report, even though the company has beaten estimates in 7 of the last 7 reports.
The trend is mixed: FCX is above its 200-day average at $65.13 but below its 50-day average at $71.81. A close above the 50-day would turn both signals up, and a close below the 200-day would turn both down. In the meantime the price sits between the 200-day SMA ($65.13) underneath and the 20-day EMA ($69.02) overhead.
FCX's RSI is in the bearish zone, a reading that argues against a fast rebound.
Technical indicators
Momentum and trend for FCX, from its daily closes.
As of October 27, 2026, with FCX at $65.95, its 14-day RSI is 37.2 (showing bearish momentum without being oversold), its 50-day simple moving average is $71.81 and its 200-day is $65.13.
Calculated by CleaRank on daily closes as of October 27, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What FCX moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 27, 2026, FCX's 1-year correlation of daily returns is +0.58 with S&P 500 (SPY), +0.58 with Nasdaq 100 (QQQ), +0.31 with Bitcoin (BTC) and +0.47 with gold (XAU).
FCX price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
18 of 23 analysts rate it a buy or strong buy, 4 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $82.00 is 24.3% above the price.More buy ratings than three months ago ›
18 of 23 rate it a buy now, against 19 of 23 three months ago.
FCX Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 19, 2026 | Barclays | Maintains | Overweight |
| Oct 8, 2026 | UBS | Maintains | Buy |
| Oct 7, 2026 | JP Morgan | Maintains | Overweight |
| Oct 7, 2026 | Morgan Stanley | Maintains | Equal-Weight |
| Oct 6, 2026 | Barclays | Maintains | Overweight |
| Oct 6, 2026 | Wells Fargo | Maintains | Overweight |
As of October 27, 2026, 23 Wall Street analysts cover FCX: 18 rate it a buy or strong buy, 4 a hold and 1 a sell or strong sell. Their 12-month price targets range from $32.00 to $92.00. The median FCX price target is $82.00, 24.3% above the price of $65.95.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
FCX trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
FCX trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from FCX's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much FCX tends to move, against the market and on its own.
FCX price history and drawdowns
FCX's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 2.03% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 66.3%, from January 2018 to March 2020, regained by November 2020.Most 1-year holds ended higher ›
59% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $66,011, against $42,015 in the S&P 500 (SPY).
FCX Drawdowns & Recovery
As of October 27, 2026, FCX's worst peak-to-trough fall over the last 10 years with dividends reinvested was -66.3% (January 2018 to March 2020); it regained that peak by November 2020, 8 months after the low, and 59% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into FCX in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: FCX beat the S&P 500 over this period: $66,011 against $42,015.
A $10,000 investment in FCX in October 2016 would be worth about $66,011 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to FCX, and which have not.
Strongest month, November: an average of +10.72%, up in 7 of 10 years.
Weakest month, March: an average of -4.36%, up in 3 of 10 years.
This month, October: has averaged +2.69%, up in 6 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, FCX's strongest calendar month has been November (average +10.72%, up in 7 of 10 years) and its weakest March (average -4.36%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
FCX stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in FCX, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in FCX today could grow to about $14,756 by 2030 in the base case, with a 90th-percentile outcome near $50,887 and a 10th-percentile outcome around $4,279. The simulation models price only; at today's 0.91% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
FCX Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $97.32 for FCX by 2030 in the base case, from $65.95 today (1.5x over 4 years). The 10th-percentile path ends near $28.22. These are outcomes of a Monte Carlo simulation run on FCX's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $39.14 | $72.69 | $135 | |
| 2028 | $33.38 | $80.11 | $192 | |
| 2029 | $30.22 | $88.30 | $258 | |
| 2030 | $28.22 | $97.32 | $336 |
Method: a lognormal simulation of FCX's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. FCX is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation. How the simulation works
FCX insider trading
What the people running the company have bought and sold.
FCX insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought FCX shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 27, 2026, FCX insiders reported 13 open-market sales worth $46.4M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Hugh N Grant
Director
|
Grant | 482 | $33.7K |
| Oct 1, 2026 | John Joseph Stephens
Director
|
Grant | 294 | $20.6K |
| Aug 27, 2026 | Lydia H Kennard
Director
|
Sell | 3.8K | $300.5K |
| Aug 25, 2026 | Douglas Nicholas Currault II
General Counsel
|
Sell | 80.0K | $6.3M |
| Aug 25, 2026 | Douglas Nicholas Currault II
General Counsel
|
Option | 80.0K | $1.2M |
| Aug 5, 2026 | Stephen T Higgins
Officer
|
Sell | 14.3K | $992.3K |
| Aug 5, 2026 | Ellie L. Mikes
Officer
|
Sell | 4.8K | $334.1K |
| Jul 30, 2026 | Stephen T Higgins
Officer
|
Sell | 7.6K | $475.7K |
| Jul 1, 2026 | Hugh N Grant
Director
|
Grant | 536 | $33.7K |
| Jul 1, 2026 | John Joseph Stephens
Director
|
Grant | 327 | $20.6K |
| Jun 1, 2026 | David P Abney
Director
|
Grant | 2.8K | - |
| Jun 1, 2026 | Marcela E. Donadio, CPA
Director
|
Grant | 2.8K | - |
| Jun 1, 2026 | Hugh N Grant
Director
|
Grant | 2.8K | - |
| Jun 1, 2026 | Lydia H Kennard
Director
|
Grant | 2.8K | - |
| Jun 1, 2026 | Ryan Michael Lance
Director
|
Grant | 2.8K | - |
| Jun 1, 2026 | Sara Grootwassink Lewis
Director
|
Grant | 2.8K | - |
| Jun 1, 2026 | Dustan E Mccoy
Director
|
Grant | 2.8K | - |
| Jun 1, 2026 | John Joseph Stephens
Director
|
Grant | 2.8K | - |
| Jun 1, 2026 | Frances Fragos Townsend, J.D.
Director
|
Grant | 2.8K | - |
| Apr 1, 2026 | Hugh N Grant
Director
|
Grant | 574 | $33.7K |
| Apr 1, 2026 | John Joseph Stephens
Director
|
Grant | 350 | $20.6K |
| Mar 6, 2026 | Richard C Adkerson
Chairman of the Board
|
Grant | 27.7K | - |
| Feb 20, 2026 | Stephen T Higgins
Officer
|
Sell | 29.7K | $1.9M |
| Feb 18, 2026 | Ellie L. Mikes
Officer
|
Sell | 11.0K | $682.3K |
| Feb 13, 2026 | Maree E Robertson
Chief Financial Officer
|
Sell | 48.5K | $3.0M |
| Feb 11, 2026 | Richard C Adkerson
Chairman of the Board
|
Sell | 401.0K | $25.5M |
| Feb 11, 2026 | Douglas Nicholas Currault II
General Counsel
|
Sell | 75.0K | $4.8M |
| Feb 11, 2026 | Douglas Nicholas Currault II
General Counsel
|
Option | 75.0K | $892.3K |
| Feb 10, 2026 | Maree E Robertson
Chief Financial Officer
|
Grant | 43.9K | - |
| Feb 9, 2026 | Richard C Adkerson
Chairman of the Board
|
Grant | 275.6K | - |
| Feb 9, 2026 | Douglas Nicholas Currault II
General Counsel
|
Grant | 34.6K | - |
| Feb 9, 2026 | Stephen T Higgins
Officer
|
Grant | 38.6K | - |
| Feb 9, 2026 | Ellie L. Mikes
Officer
|
Grant | 18.0K | - |
| Feb 9, 2026 | Kathleen L. Quirk
Chief Executive Officer
|
Grant | 179.5K | - |
| Dec 31, 2025 | Hugh N Grant
Director
|
Grant | 664 | $33.7K |
| Dec 31, 2025 | John Joseph Stephens
Director
|
Grant | 406 | $20.6K |
| Dec 11, 2025 | Stephen T Higgins
Officer
|
Sell | 28.4K | $1.4M |
| Dec 11, 2025 | Ellie L. Mikes
Officer
|
Sell | 9.6K | $456.2K |
| Nov 28, 2025 | Richard C Adkerson
Chairman of the Board
|
Grant | 28.8K | - |
| Oct 1, 2025 | Hugh N Grant
Director
|
Grant | 860 | $33.7K |
| Oct 1, 2025 | John Joseph Stephens
Director
|
Grant | 525 | $20.6K |
| Aug 25, 2025 | Richard C Adkerson
Chairman of the Board
|
Grant | 25.7K | - |
| Jul 1, 2025 | Hugh N Grant
Director
|
Grant | 778 | $33.7K |
| Jul 1, 2025 | John Joseph Stephens
Director
|
Grant | 475 | $20.6K |
| Jun 2, 2025 | Ellie L. Mikes
Officer
|
Sell | 8.6K | $343.5K |
| May 30, 2025 | David P Abney
Director
|
Grant | 4.9K | - |
| May 30, 2025 | Marcela E. Donadio, CPA
Director
|
Grant | 4.9K | - |
| May 30, 2025 | Robert W Dudley
Director
|
Grant | 4.9K | - |
| May 30, 2025 | Hugh N Grant
Director
|
Grant | 4.9K | - |
| May 30, 2025 | Lydia H Kennard
Director
|
Grant | 4.9K | - |
| May 30, 2025 | Ryan Michael Lance
Director
|
Grant | 4.9K | - |
| May 30, 2025 | Sara Grootwassink Lewis
Director
|
Grant | 4.9K | - |
| May 30, 2025 | Dustan E Mccoy
Director
|
Grant | 4.9K | - |
| May 30, 2025 | John Joseph Stephens
Director
|
Grant | 4.9K | - |
| May 30, 2025 | Frances Fragos Townsend, J.D.
Director
|
Grant | 4.9K | - |
| May 12, 2025 | Richard C Adkerson
Chairman of the Board
|
Grant | 44.8K | - |
Source: TwelveData, from SEC Form 4 filings
FCX stock forecast: questions people ask
Answered from the figures on this page, as of October 27, 2026.